On Tuesday, Alphatec Holdings hit an important performance benchmark, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 91, up from 88 the day before.
IBD's unique rating measures share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains typically have an 80 or better RS Rating at the beginning of a new price run.
Looking For The Best Stocks To Buy And Watch? Start Here
Alphatec Holdings is still within a buy range after climbing above a 10.63 entry in a cup without handle. Once a stock moves 5% or higher beyond the original entry, it's considered out of a proper buying area.
The company reported 0% EPS growth last quarter, while sales growth came in at 27%.
Alphatec Holdings earns the No. 34 rank among its peers in the Medical-Products industry group. Globus Medical, Boston Scientific and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
